Effects of dietary fruits, vegetables and a herbal tea on the in vitro transport of cimetidine: Comparing the Caco-2 model with porcine jejunum tissue

References

• Artursson P, Palm K, Luthman K. (2001). Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv Drug Deliv Rev, 46, 27–43.
   PubMed Web of Science ®Google Scholar
• Bansal T, Mishra G, Jaggi M, Khar RK, Talegaonkar S. (2009). Effect of P-glycoprotein inhibitor, verapamil, on oral bioavailability and pharmacokinetics of irinotecan in rats. Eur j Pharm Sci, 36, 580–590.
   PubMed Web of Science ®Google Scholar
• Colalto C. (2010). Herbal interactions on absorption of drugs: Mechanisms of action and clinical risk assessment. Pharmacol Res, 62, 207–227.
   PubMed Web of Science ®Google Scholar
• Collett A, Higgs NB, Sims E, Rowland M, Warhurst G. (1999). Modulation of the permeability of H2 receptor antagonists cimetidine and ranitidine by P-glycoprotein in rat intestine and the human colonic cell line Caco-2. J Pharmacol Exp Ther, 288, 171–178.
   PubMed Web of Science ®Google Scholar
• Döppenschmitt S, Spahn-Langguth H, Regårdh CG, Langguth P. (1999). Role of P-glycoprotein-mediated secretion in absorptive drug permeability: An approach using passive membrane permeability and affinity to P-glycoprotein. J Pharm Sci, 88, 1067–1072.
   PubMed Web of Science ®Google Scholar
• Dudley AJ, Brown CD. (1996). Mediation of cimetidine secretion by P-glycoprotein and a novel H(+)-coupled mechanism in cultured renal epithelial monolayers of LLC-PK1 cells. Br J Pharmacol, 117, 1139–1144.
   PubMed Web of Science ®Google Scholar
• Elsby R, Surry DD, Smith VN, Gray AJ. (2008). Validation and application of Caco-2 assays for the in vitro evaluation of development candidate drugs as substrates or inhibitors of P-glycoprotein to support regulatory submissions. Xenobiotica, 38, 1140–1164.
   PubMed Web of Science ®Google Scholar
• Farkas D, Greenblatt DJ. (2008). Influence of fruit juices on drug disposition: Discrepancies between in vitro and clinical studies. Expert Opin Drug Metab Toxicol, 4, 381–393.
   PubMed Web of Science ®Google Scholar
• Guti’érrez RMP, Mitchell S, Solis RV. (2008). Psidium guajava: A review of its traditional uses, phytochemistry and pharmacology. J Ethnophamacol, 117, 1–27.
   PubMed Web of Science ®Google Scholar
• Hansen TS, Nilsen OG. (2009). Echinacea purpurea and P-glycoprotein drug transport in Caco-2 cells. Phytother Res, 23, 86–91.
   PubMed Web of Science ®Google Scholar
• Harris RZ, Jang GR, Tsunoda S. (2003). Dietary effects on drug metabolism and transport. Clin Pharmacokinet, 42, 1071–1088.
   PubMed Web of Science ®Google Scholar
• Hayeshi R, Masimirembwa C, Mukanganyama S, Ungell AL. (2006). The potential inhibitory effect of antiparasitic drugs and natural products on P-glycoprotein mediated efflux. Eur J Pharm Sci, 29, 70–81.
   PubMed Web of Science ®Google Scholar
• Hsiu SL, Hou YC, Wang YH, Tsao CW, Su SF, Chao PD. (2002). Quercetin significantly decreased cyclosporin oral bioavailability in pigs and rats. Life Sci, 72, 227–235.
   PubMed Web of Science ®Google Scholar
• Ingersoll RE. (2005). Herbaceuticals: An overview for counselors. J Counsel Dev, 83, 434–443.
   Web of Science ®Google Scholar
• Jantratid E, Prakongpan S, Dressman JB, Amidon GL, Junginger HE, Midha KK, Barends DM. (2006). Biowaiver monographs for immediate release solid oral dosage forms: cimetidine. J Pharm Sci, 95, 974–984.
   PubMed Web of Science ®Google Scholar
• Katragadda S, Budda B, Anand BS, Mitra AK. (2005). Role of efflux pumps and metabolising enzymes in drug delivery. Expert Opin Drug Deliv, 2, 683–705.
   PubMedGoogle Scholar
• Laffont CM, De Vrieze G, Maas R, Bousquet-Mélou A, Fink-Gremmels J. (2003). Comparative evaluation of p-gp activity in cattle, sheep, goats, pigs, horses, and rats using a limphocyte-based ex vivo model. J Vet Pharm Therap, 26, 82–307.
   Google Scholar
• Legen I, Salobir M, Kerc J. (2005). Comparison of different intestinal epithelia as models for absorption enhancement studies. Int J Pharm, 291, 183–188.
   PubMedGoogle Scholar
• Mandava N, Oberol RK, Minocha M, Mitra AK. (2010). Transporter targeted drug delivery. J Drug Deliv Sci Technol, 20, 89–99.
   Web of Science ®Google Scholar
• Neirinckx E, Vervaet C, Michiels J, De Smet S, Van den Broeck W, Remon JP, De Backer P, Croubels S. (2011). Feasibility of the Ussing chamber technique for the determination of in vitro jejunal permeability of passively absorbed compounds in different animal species. J Vet Pharmacol Ther, 34, 290–297.
   PubMed Web of Science ®Google Scholar
• Rubas W, Jezyk N, Grass GM. (1993). Comparison of the permeability characteristics of a human colonic epithelial (Caco-2) cell line to colon of rabbit, monkey, and dog intestine and human drug absorption. Pharm Res, 10, 113–118.
   PubMed Web of Science ®Google Scholar
• Schwarz UI, Seemann D, Oertel R, Miehlke S, Kuhlisch E, Fromm MF, Kim RB, Bailey DG, Kirch W. (2005). Grapefruit juice ingestion significantly reduces talinolol bioavailability. Clin Pharmacol Ther, 77, 291–301.
   PubMed Web of Science ®Google Scholar
• Sica DA. (2006). Interaction of grapefruit juice and calcium channel blockers. Am J Hypertens, 19, 768–773.
   PubMed Web of Science ®Google Scholar
• Spahn-Langguth H, Langguth P. (2001). Grapefruit juice enhances intestinal absorption of the P-glycoprotein substrate talinolol. Eur J Pharm Sci, 12, 361–367.
   PubMed Web of Science ®Google Scholar
• Sukhai M, Piquette-Miller M. (2000). Regulation of the multidrug resistance genes by stress signals. J Pharm Pharm Sci, 3, 268–280.
   PubMed Web of Science ®Google Scholar
• Sun J, He ZG, Cheng G, Wang SJ, Hao XH, Zou MJ. (2004). Multidrug resistance P-glycoprotein: crucial significance in drug disposition and interaction. Med Sci Monit, 10, RA5–R14.
   PubMed Web of Science ®Google Scholar
• Takagi T, Ramachandran C, Bermejo M, Yamashita S, Yu LX, Amidon GL. (2006). A provisional biopharmaceutical classification of the top 200 oral drug products in the United States, Great Britain, Spain, and Japan. Mol Pharm, 3, 631–643.
   PubMed Web of Science ®Google Scholar
• Tang H, Pak Y, Mayersohn M. (2004). Protein expression pattern of P-glycoprotein along the gastrointestinal tract of the Yucatan micropig. J Biochem Mol Toxicol, 18, 18–22.
   PubMed Web of Science ®Google Scholar
• Tarirai C, Viljoen AM, Hamman JH. (2010). Herb-drug pharmacokinetic interactions reviewed. Expert Opin Drug Metab Toxicol, 6, 1515–1538.
   PubMed Web of Science ®Google Scholar
• Taur JS, Rodriguez-Proteau R. (2008). Effects of dietary flavonoids on the transport of cimetidine via P-glycoprotein and cationic transporters in Caco-2 and LLC-PK1 cell models. Xenobiotica, 38, 1536–1550.
   PubMed Web of Science ®Google Scholar
• Varma MV, Ashokraj Y, Dey CS, Panchagnula R. (2003). P-glycoprotein inhibitors and their screening: A perspective from bioavailability enhancement. Pharmacol Res, 48, 347–359.
   PubMed Web of Science ®Google Scholar
• Varma MV, Perumal OP, Panchagnula R. (2006). Functional role of P-glycoprotein in limiting peroral drug absorption: optimizing drug delivery. Curr Opin Chem Biol, 10, 367–373.
   PubMed Web of Science ®Google Scholar
• Viljoen AM, Kamatou GPP, Basér KHC. (2008). Head-space volatiles of marula (Sclerocarya birrea subsp. caffra). S Afr J Bot, 74, 325–326.
   Web of Science ®Google Scholar